Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 12, Pages 3742
Publisher
MDPI AG
Online
2020-12-14
DOI
10.3390/cancers12123742
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Azacitidine Is Effective in MDS and AML Patients: Ongoing Phase 1b Results
- (2020) David A Sallman et al. BLOOD
- Flotetuzumab, an Investigational CD123 x CD3 Bispecific Dart® Protein, in Salvage Therapy for Primary Refractory and Early Relapsed Acute Myeloid Leukemia (AML) Patients
- (2020) Geoffrey L. Uy et al. BLOOD
- CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy
- (2020) Ross Kinstrie et al. LEUKEMIA
- Rapidly Switchable Universal CAR-T cells for Treatment of CD123-positive Leukemia
- (2020) Simon Loff et al. Molecular Therapy-Oncolytics
- CD34+CD38−CD123+ Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents
- (2020) François Vergez et al. Cancers
- Role of CD47 in Hematological Malignancies
- (2020) Entsar Eladl et al. Journal of Hematology & Oncology
- Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents
- (2020) Carsten Riether et al. NATURE MEDICINE
- Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia
- (2020) Heejoo Han et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Delineation of target expression profiles in CD34+/CD38− and CD34+/CD38+ stem and progenitor cells in AML and CML
- (2020) Harald Herrmann et al. Blood Advances
- CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
- (2019) Lucas Touzet et al. Cancer Medicine
- High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML
- (2019) Shruti Daga et al. Cancer Medicine
- Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in AML
- (2019) Daniel Sasca et al. BLOOD
- Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML.
- (2019) Swati Garg et al. BLOOD
- Targeting CLL-1 for acute myeloid leukemia therapy
- (2019) Hongbing Ma et al. Journal of Hematology & Oncology
- Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
- (2019) Anna M. Paczulla et al. NATURE
- The effects of monoclonal anti‐CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia
- (2019) C.K. Brierley et al. TRANSFUSION
- The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases
- (2019) Kelly A. Hogan et al. Frontiers in Immunology
- CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies
- (2019) Testa et al. Cancers
- A Phase 1 Study of Flotetuzumab, a CD123 x CD3 DART® Protein, Combined with MGA012, an Anti-PD-1 Antibody, in Patients with Relapsed or Refractory Acute Myeloid Leukemia
- (2019) Andrew H. Wei et al. BLOOD
- Single-cell gene expression analyses reveal distinct self-renewing and proliferating subsets in the leukemia stem cell compartment in acute myeloid leukemia
- (2019) Karen Sachs et al. CANCER RESEARCH
- CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth
- (2019) Victoria M.-Y. Wang et al. NATURE CELL BIOLOGY
- Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
- (2018) S. Haubner et al. LEUKEMIA
- A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells
- (2018) Keisuke Sumide et al. Nature Communications
- NKG2D and Its Ligands: “One for All, All for One”
- (2018) Alessandra Zingoni et al. Frontiers in Immunology
- Coming of Age: CD96 Emerges as Modulator of Immune Responses
- (2018) Hristo Georgiev et al. Frontiers in Immunology
- Survival outcomes of CD34+CD38−LSCs and their expression of CD123 in adult AML patients
- (2018) Asmaa M. Zahran et al. Oncotarget
- Suppression of GPR56 expression by pyrrole-imidazole polyamide represents a novel therapeutic drug for AML with high EVI1 expression
- (2018) Hasi Rani Saha et al. Scientific Reports
- The Activation and Signaling Mechanisms of GPR56/ADGRG1 in Melanoma Cell
- (2018) Kuan-Yeh Huang et al. Frontiers in Oncology
- CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping
- (2018) Anne E. Bras et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Histone deacetylase inhibitor targets CD123/CD47-positive cells and reverse chemoresistance phenotype in acute myeloid leukemia
- (2018) Bowen Yan et al. LEUKEMIA
- Expression of CD25 fluctuates in the leukemia-initiating cell population of CD25-positive AML
- (2018) Yuki Kageyama et al. PLoS One
- The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody–drug conjugate for the treatment of newly diagnosed acute myeloid leukemia
- (2018) Pamela C Egan et al. OncoTargets and Therapy
- The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment
- (2018) Laura Agresta et al. Frontiers in Immunology
- CD9 Tetraspanin: A New Pathway for the Regulation of Inflammation?
- (2018) Carole Brosseau et al. Frontiers in Immunology
- MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients
- (2017) Maria Paprocka et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- CD244 maintains the proliferation ability of leukemia initiating cells through SHP-2/p27 kip1 signaling
- (2017) Feifei Zhang et al. HAEMATOLOGICA
- Leukemic stem cells: identification and clinical application
- (2017) Diana Hanekamp et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Expression of multiple leukemic stem cell markers is associated with poor prognosis in de novo acute myeloid leukemia
- (2017) Tomohiro Yabushita et al. LEUKEMIA & LYMPHOMA
- Understanding of leukemic stem cells and their clinical implications
- (2017) Xuefei Wang et al. Molecular Cancer
- SIRPα-antibody fusion proteins stimulate phagocytosis and promote elimination of acute myeloid leukemia cells
- (2017) Laia Pascual Ponce et al. Oncotarget
- CD244 maintains the proliferation ability of leukemia initiating cells through SHP-2/p27 kip1 signaling
- (2017) Feifei Zhang et al. HAEMATOLOGICA
- CD56 in the Immune System: More Than a Marker for Cytotoxicity?
- (2017) Heleen H. Van Acker et al. Frontiers in Immunology
- Hematopoietic Stem Cell Niche in Health and Disease
- (2016) Jonathan Hoggatt et al. Annual Review of Pathology-Mechanisms of Disease
- GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo
- (2016) C. Pabst et al. BLOOD
- Evolution of acute myelogenous leukemia stem cell properties after treatment and progression
- (2016) T.-C. Ho et al. BLOOD
- CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia
- (2016) Bas Kersten et al. BRITISH JOURNAL OF HAEMATOLOGY
- The hematopoietic stem-cell niche in health and leukemia
- (2016) Abel Sánchez-Aguilera et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
- (2016) C. Klemann et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding
- (2016) Penka S. Petrova et al. CLINICAL CANCER RESEARCH
- Genetically distinct leukemic stem cells in human CD34−acute myeloid leukemia are arrested at a hemopoietic precursor-like stage
- (2016) Lynn Quek et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia
- (2016) Carsten Riether et al. JOURNAL OF EXPERIMENTAL MEDICINE
- GPR56 contributes to the development of acute myeloid leukemia in mice
- (2016) D Daria et al. LEUKEMIA
- Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia
- (2016) N Khan et al. LEUKEMIA
- A 17-gene stemness score for rapid determination of risk in acute leukaemia
- (2016) Stanley W. K. Ng et al. NATURE
- ‘Acute myeloid leukemia: a comprehensive review and 2016 update’
- (2016) I De Kouchkovsky et al. Blood Cancer Journal
- Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia
- (2016) Norbert Vey et al. Oncotarget
- CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia
- (2015) Masayuki Iwasaki et al. Cell Stem Cell
- A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia
- (2015) D. F. Angelini et al. CLINICAL CANCER RESEARCH
- A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemia
- (2015) W Zeijlemaker et al. LEUKEMIA
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review Cancer stem cells in haematological malignancies
- (2015) Radoslaw Zagozdzon et al. Wspolczesna Onkologia-Contemporary Oncology
- Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
- (2015) Jie Liu et al. PLoS One
- The past and future of CD33 as therapeutic target in acute myeloid leukemia
- (2014) George S. Laszlo et al. BLOOD REVIEWS
- Regulation of hematopoietic and leukemic stem cells by the immune system
- (2014) C Riether et al. CELL DEATH AND DIFFERENTIATION
- Whole-transcriptome analysis of endothelial to hematopoietic stem cell transition reveals a requirement for Gpr56 in HSC generation
- (2014) Parham Solaimani Kartalaei et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo
- (2014) I Pizzitola et al. LEUKEMIA
- Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
- (2014) Liran I. Shlush et al. NATURE
- Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
- (2014) A Ehninger et al. Blood Cancer Journal
- Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia
- (2014) Jianbiao Zhou World Journal of Stem Cells
- Tim-3: An Activation Marker and Activation Limiter of Innate Immune Cells
- (2013) Gencheng Han et al. Frontiers in Immunology
- CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest
- (2012) E Sick et al. BRITISH JOURNAL OF PHARMACOLOGY
- Defining a functionally distinct subset of human memory CD4+ T cells that are CD25POS and FOXP3NEG
- (2012) Todd A. Triplett et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts
- (2012) Alexandre P.A. Theocharides et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Expression of CD200 on AML blasts directly suppresses memory T-cell function
- (2012) S J Coles et al. LEUKEMIA
- A Proteomics and Transcriptomics Approach to Identify Leukemic Stem Cell (LSC) Markers
- (2012) Francesco Bonardi et al. MOLECULAR & CELLULAR PROTEOMICS
- Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia
- (2011) Nicolas Goardon et al. CANCER CELL
- Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up
- (2011) Hanne Ø. Larsen et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study
- (2011) F. Vergez et al. HAEMATOLOGICA
- CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia
- (2011) S J Coles et al. LEUKEMIA
- Stem cell gene expression programs influence clinical outcome in human leukemia
- (2011) Kolja Eppert et al. NATURE MEDICINE
- Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker
- (2011) M. Jan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34- fraction
- (2010) D. C. Taussig et al. BLOOD
- A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting
- (2010) Markus Kügler et al. BRITISH JOURNAL OF HAEMATOLOGY
- TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
- (2010) Yoshikane Kikushige et al. Cell Stem Cell
- Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice
- (2010) Jean-Emmanuel Sarry et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells
- (2010) Y. Saito et al. Science Translational Medicine
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
- (2009) Siddhartha Jaiswal et al. CELL
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Control of Stem Cell Fate by Physical Interactions with the Extracellular Matrix
- (2009) Farshid Guilak et al. Cell Stem Cell
- Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells
- (2009) Liqing Jin et al. Cell Stem Cell
- CD90 Expression on human primary cells and elimination of contaminating fibroblasts from cell cultures
- (2009) Lynn Kisselbach et al. CYTOTECHNOLOGY
- Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia
- (2009) M Jawad et al. LEUKEMIA
- CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
- (2009) R. L. Silverstein et al. Science Signaling
- CD93 and Related Family Members: Their Role in Innate Immunity
- (2008) S. Bohlson et al. CURRENT DRUG TARGETS
- Novel functions of the CD34 family
- (2008) J. S. Nielsen et al. JOURNAL OF CELL SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started